Aspiring for quality and service
Retinal vein thrombosis: pathogenesis and management
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting
Adipokines are associated with lower extremity venous disease: the San Diego population study
Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations
Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism
Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension
Iliac vein thrombosis: feasibility assessment of randomized controlled trials of endovascular pharmacomechanical thrombolysis
Population pharmacokinetics of enoxaparin in infants, children and adolescents during secondary thromboembolic prophylaxis: a cohort study
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty
Zn2+-containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor
von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy
Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells
Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype
Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis
Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests
A Gi-independent mechanism mediating Akt phosphorylation in platelets
Tissue factor up-regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non-coagulant properties in vitro
Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura
ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders
International Collaborative Study for the Calibration of a Proposed International Standard for thromboplastin, human, plain
The frequency of prescription of P-glycoprotein-affecting drugs in atrial fibrillation
False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant
β2-Glycoprotein I-derived peptides as antigenic structures for the detection of antiphospholipid antibodies
Increased representation of the PTPN22 mutation in patients with immune thrombocytopenia
Blood group significantly influences von Willebrand factor increase and half-life after desmopressin in von Willebrand disease Vicenza
Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes
Predominance of left-sided deep vein thrombosis and body weight
A mutation in the acyl-coenzyme A binding domain-containing protein 5 gene ( ACBD5  ) identified in autosomal dominant thrombocytopenia
More on: new antithrombotics: a need for laboratory monitoring. For or against
Short by one mechanism: a rebuttal
Single fibrin fiber experiments suggest longitudinal rather than transverse cross-linking: reply to a rebuttal